A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 1, 2009, Pages

  Fourcade, Stéphane ^a,b,c   Ruiz, Montserrat ^a,b,c,d   Camps, Carme ^d   Schlüter, Agatha ^a,b,c   Houten, Sander M ^e   Mooyer, Petra A W ^e   Pàmpols, Teresa ^c,d   Dacremont, Georges ^f   Wanders, Ronald J A ^e   Giròs, Marisa ^c,d   Pujol, Aurora ^a,b,c,g,h  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f GHENT UNIVERSITY   (Belgium)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

Adenosine 5 triphosphate binding cassette transporters; Adrenoleukodystrophy; Docosahex anoic acid; Peroxisome; Polyunsaturated fatty acid

Indexed keywords

ABC TRANSPORTER; ABCD1 PROTEIN; ABCD2 PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; LONG CHAIN FATTY ACID; MONOUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET; FATTY ACID METABOLISM; FEMALE; INCIDENCE; KNOCKOUT MOUSE; LIPID DEGRADATION; MALE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL;

EID: 58249098638     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90736.2008     Document Type: Article

References (68)

1. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21: 2104-2105, 2005.
2. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
3. Boles DJ, Craft DA, Padgett DA, Loria RM, Rizzo WB. Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts. Biochem Med Metab Biol 45: 74-91, 1991.
4. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10: 386-399, 2006.
5. Bremer J. The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects. Prog Lipid Res 40: 231-268, 2001.
6. Christensen E, Hagve TA, Christophersen BO. The Zellweger syndrome: deficient chain-shortening of erucic acid [22:1 (n-9)] and adrenic acid [22:4 (n-6)] in cultured skin fibroblasts. Biochim Biophys Acta 959: 134-142, 1988.
7. Christiansen RZ. The effect of clofibrate-feeding on hepatic fatty acid metabolism. Biochim Biophys Acta 530: 314-324, 1978.
8. De Duve C, Baudhuin P. Peroxisomes (microbodies and related particles). Physiol Rev 46: 323-357, 1966.
9. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
10. Drummond A, Strimmer K. PAL: an object-oriented programming library for molecular evolution and phylogenetics. Bioinformatics 17: 662-663, 2001.
11. Ferdinandusse S, Denis S, Dacremont G, Wanders RJ. Studies on the metabolic fate of n-3 polyunsaturated fatty acids. J Lipid Res 44: 1992-1997, 2003.
12. Ferrer I, Kapfhammer JP, Hindelang C, Kemp S, Troffer-Charlier N, Broccoli V, Callyzot N, Mooyer P, Selhorst J, Vreken P, Wanders RJ, Mandel JL, Pujol A. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum Mol Genet 14: 3565-3577, 2005.
13. Footitt S, Slocombe SP, Larner V, Kurup S, Wu Y, Larson T, Graham I, Baker A, Holdsworth M. Control of germination and lipid mobilization by COMATOSE, the Arabidopsis homologue of human ALDP. EMBO J 21: 2912-2922, 2002.
14. Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50: 829-843, 1997.
15. Geertsma ER, Nik Mahmood NA, Schuurman-Wolters GK, Poolman B. Membrane reconstitution of ABC transporters and assays of transloca-tor function. Nat Protoc 3: 256-266, 2008.
16. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704, 2003.
17. Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22: 383-415, 2002.
18. Harris WS, Reid KJ, Sands SA, Spertus JA. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 99: 154-158, 2007.
19. Heinzer AK, Watkins PA, Lu JF, Kemp S, Moser AB, Li YY, Mihalik S, Powers JM, Smith KD. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12: 1145-1154, 2003.
20. Hettema EH, van Roermund CW, Distel B, van den Berg M, Vilela C, Rodrigues-Pousada C, Wanders RJ, Tabak HF. The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae. EMBO J 15: 3813-3822, 1996.
21. Hoepfner D, Schildknegt D, Braakman I, Philippsen P, Tabak HF. Contribution of the endoplasmic reticulum to peroxisome formation. Cell 122: 85-95, 2005.
22. Janssen A, Baes M, Gressens P, Mannaerts GP, Declercq P, Van Veldhoven PP. Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice. Lab Invest 80: 31-35, 2000.
23. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 135: 2503-2506, 2005.
24. Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem 265: 4534-4540, 1990.
25. Kan I, Melamed E, Offen D, Green P. Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuro-nal differentiation. J Lipid Res 48: 513-517, 2007.
26. Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S. Serotoninergic neurotransmission is affected by n-3 poly-unsaturated fatty acids in the rat. J Neurochem 89: 695-702, 2004.
27. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5: 150-163, 2004.
28. Langmann T, Mauerer R, Zahn A, Moehle C, Probst M, Stremmel W, Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 49: 230-238, 2003.
29. Lauretani F, Bandinelli S, Bartali B, Cherubini A, Iorio AD, Ble A, Giacomini V, Corsi AM, Guralnik JM, Ferrucci L. Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons. Eur J Neurol 14: 801-808, 2007.
30. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40: 1-94, 2001.
31. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27: 114-120, 1986.
32. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277: 9520-9528, 2002.
33. Lombard-Platet G, Savary S, Sarde CO, Mandel JL, Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci USA 93: 1265-1269, 1996.
34. Louet JF, Chatelain F, Decaux JF, Park EA, Kohl C, Pineau T, Girard J, Pegorier JP. Long-chain fatty acids regulate liver carnitine palmitoyl-transferase I gene (L-CPT I) expression through a peroxisome- prolifera-tor-activated receptor alpha (PPARalpha)-independent pathway. Biochem J 354: 189-197, 2001.
35. Lu JF, Barron-Casella E, Deering R, Heinzer AK, Moser AB, deMesy Bentley KL, Wand GS, McGuinness M, Pei Z, Watkins PA, Pujol A, Smith KD, Powers JM. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage. Lab Invest 87: 261-272, 2007.
36. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94: 9366-9371, 1997.
37. Martinez M. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res 583: 171-182, 1992.
38. McGuinness MC, Lu JF, Zhang HP, Dong GX, Heinzer AK, Watkins PA, Powers J, Smith KD. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol Cell Biol 23: 744-753, 2003.
39. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75: 329-349, 2006.
40. Moore SA, Hurt E, Yoder E, Sprecher H, Spector AA. Docosahexae-noic acid synthesis in human skin fibroblasts involves peroxisomal retro-conversion of tetracosahexaenoic acid. J Lipid Res 36: 2433-2443, 1995.
41. Nagao K, Yanagita T. Bioactive lipids in metabolic syndrome. Prog Lipid Res 47: 127-146, 2008.
42. Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol Genet 8: 907-913, 1999.
43. Nicholas KB, Nicholas HB, Deerfield DW 2nd. GeneDOC. EMBnet 4: 1-4, 1997.
44. Norseth J, Thomassen MS. Stimulation of microperoxisomal beta-oxidation in rat heart by high-fat diets. Biochim Biophys Acta 751: 312-320, 1983.
45. Powers JM, Moser HW. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8: 101-120, 1998.
46. Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, Ruiz M, Pampols T, Giros M, Mandel JL. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13: 2997-3006, 2004.
47. Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11: 499-505, 2002.
48. Rodriguez-Cruz M, Tovar AR, Palacios-Gonzalez B, Del Prado M, Torres N. Synthesis of long-chain polyunsaturated fatty acids in lactating mammary gland: role of delta5 and delta6 desaturases, SREBP-1, PPARal-pha, and PGC-1. J Lipid Res 47: 553-560, 2006.
49. Rost B, Fariselli P, Casadio R. Topology prediction for helical trans-membrane proteins at 86% accuracy. Protein Sci 5: 1704-1718, 1996.
50. Rost B, Yachdav G, Liu J. The PredictProtein server. Nucleic Acids Res 32: W321-W326, 2004.
51. Salem NJ, Kim HY, Yergey JA. Docosahexaenoic acid: membrane function and metabolism. In: Health Effects of Polyunsaturated Fatty Acids in Seafoods, edited by Simopoulos AP, Kifer RR, Martin R. New York: Academic, 1986, p. 263-317.
52. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 62: 333-339, 2004.
53. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcho-line docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63: 1545-1550, 2006.
54. Schluter A, Fourcade S, Domenech-Estevez E, Gabaldon T, Huerta-Cepas J, Berthommier G, Ripp R, Wanders RJ, Poch O, Pujol A. PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease. Nucleic Acids Res 35: D815-D822, 2007.
55. Schluter A, Fourcade S, Ripp R, Mandel JL, Poch O, Pujol A. The \evolutionary origin of peroxisomes: an ER-peroxisome connection. Mol Biol Evol 23: 838-845, 2006.
56. Schmitz G, Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 1735: 1-19, 2005.
57. Shani N, Jimenez-Sanchez G, Steel G, Dean M, Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. Hum Mol Genet 6: 1925-1931, 1997.
58. Shani N, Valle D. A Saccharomyces cerevisiae homolog of the human adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding cassette transporters. Proc Natl Acad Sci USA 93: 11901-11906, 1996.
59. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486: 219-231, 2000.
60. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182, 1991.
61. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882, 1997.
62. Troffer-Charlier N, Doerflinger N, Metzger E, Fouquet F, Mandel JL, Aubourg P. Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. Eur J Cell Biol 75: 254-264, 1998.
63. Verleur N, Hettema EH, van Roermund CW, Tabak HF, Wanders RJ. Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system. Eur J Biochem 249: 657-661, 1997.
64. Visser WF, van Roermund CW, Ijlst L, Waterham HR, Wanders RJ. Metabolite transport across the peroxisomal membrane. Biochem J 401: 365-375, 2007.
65. Wanders RJ, Denis S, Ruiter JP, Schutgens RB, van Roermund CW, Jacobs BS. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J Inherit Metab Dis 18 Suppl 1: 113-124, 1995.
66. Wanders RJ, Vreken P, Ferdinandusse S, Jansen GA, Waterham HR, van Roermund CW, Van Grunsven EG. Peroxisomal fatty acid alpha-and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 29: 250-267, 2001.
67. Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 75: 295-332, 2006.
68. Wanders RJ, Waterham HR. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 67: 107-133, 2005.